These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 6610418)

  • 1. Tumoricidal activation of murine alveolar macrophages by muramyldipeptide substituted mannosylated serum albumin.
    Monsigny M; Roche AC; Bailly P
    Biochem Biophys Res Commun; 1984 Jun; 121(2):579-84. PubMed ID: 6610418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective macrophage activation by muramyldipeptide bound to monoclonal antibodies specific for mouse tumor cells.
    Roche AC; Bailly P; Midoux P; Monsigny M
    Cancer Immunol Immunother; 1984; 18(3):155-9. PubMed ID: 6568872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrophage activation by MDP bound to neoglycoproteins: metastasis eradication in mice.
    Roche AC; Bailly P; Monsigny M
    Invasion Metastasis; 1985; 5(4):218-32. PubMed ID: 4008192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abrogation of species specificity for activation of tumoricidal properties in macrophages by recombinant mouse or human interferon-gamma encapsulated in liposomes.
    Fidler IJ; Fogler WE; Kleinerman ES; Saiki I
    J Immunol; 1985 Dec; 135(6):4289-96. PubMed ID: 3934281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective effect of neoglycoprotein-conjugated muramyl dipeptide against Leishmania donovani infection: the role of cytokines.
    Sarkar K; Das PK
    J Immunol; 1997 Jun; 158(11):5357-65. PubMed ID: 9164956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential value of liposomes containing muramyl dipeptide for augmenting the tumoricidal activity of human alveolar macrophages.
    Sone S; Tachibana K; Shono M; Ogushi F; Tsubura E
    J Biol Response Mod; 1984; 3(2):185-94. PubMed ID: 6726281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Photoaffinity labelling of macrophages and B-lymphocytes using 125I-labelled aryl-azide derivatives of muramyldipeptide.
    Tenu JP; Adam A; Souvannavong V; Yapo A; Petit JF; Douglas K
    Int J Immunopharmacol; 1989; 11(6):653-61. PubMed ID: 2807637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic activation by lymphokines and muramyl dipeptide of tumoricidal properties in rat alveolar macrophages.
    Sone S; Fidler IJ
    J Immunol; 1980 Dec; 125(6):2454-60. PubMed ID: 7430635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The activation of tumoricidal properties in macrophages of endotoxin responder and nonresponder mice by liposome-encapsulated immunomodulators.
    Fogler WE; Talmadge JE; Fidler IJ
    J Reticuloendothel Soc; 1983 Mar; 33(3):165-74. PubMed ID: 6834360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activation of rat liver macrophages to tumoricidal activity by free or liposome-encapsulated muramyl dipeptide.
    Daemen T; Veninga A; Roerdink FH; Scherphof GL
    Cancer Res; 1986 Sep; 46(9):4330-5. PubMed ID: 3731091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative effect of muramyl dipeptide in vivo and in vitro on the tumoricidal activity of rat peritoneal macrophages.
    Reisser D; Jeannin JF; Lagadec P; Martin F
    J Biol Response Mod; 1985 Oct; 4(5):460-3. PubMed ID: 4078593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic activation by recombinant mouse interferon-gamma and muramyl dipeptide of tumoricidal properties in mouse macrophages.
    Saiki I; Fidler IJ
    J Immunol; 1985 Jul; 135(1):684-8. PubMed ID: 3923117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human alveolar macrophages: potentiation of their tumoricidal activity by liposome-encapsulated muramyl dipeptide.
    Sone S; Tsubura E
    J Immunol; 1982 Sep; 129(3):1313-7. PubMed ID: 7108208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrophage activation by muramyl dipeptide bound to neoglycoproteins and glycosylated polymers: cytotoxic factor production.
    Petit C; Monsigny M; Roche AC
    J Biol Response Mod; 1990 Feb; 9(1):33-43. PubMed ID: 2319259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antitumoral activation of rat peritoneal macrophages by muramyl dipeptide in vitro].
    Reisser D; Jeannin JF; Martin F
    C R Seances Acad Sci III; 1982 Nov; 295(8):485-8. PubMed ID: 6819063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activated porcine alveolar macrophages: are biological response modifiers the answer?
    Chapes SK; Chitko CG; Thaler RC; Nelssen JL; Anderson GA; Blecha F
    Vet Immunol Immunopathol; 1989 Aug; 22(1):91-9. PubMed ID: 2603387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of alveolar macrophage tumoricidal activity and eradication of experimental metastases by freeze-dried liposomes containing a new lipophilic muramyl dipeptide derivative.
    Phillips NC; Moras ML; Chedid L; Lefrancier P; Bernard JM
    Cancer Res; 1985 Jan; 45(1):128-34. PubMed ID: 3838084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MDP and LPS act synergistically to induce arginine-dependent cytostatic activity in rat alveolar macrophages.
    Barratt GM; Raddassi K; Petit JF; Tenu JP
    Int J Immunopharmacol; 1991; 13(2-3):159-65. PubMed ID: 2071293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of antitumor properties in alveolar macrophages from protein-calorie malnourished rats.
    Mutsuura S; Sone S; Tsubura E; Tachibana K; Kishino Y
    Cancer Immunol Immunother; 1986; 21(1):63-8. PubMed ID: 3080228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrophage activation for antitumour function by muramyl dipeptide-protein conjugates.
    Tabata Y; Ikada Y
    J Pharm Pharmacol; 1990 Jan; 42(1):13-9. PubMed ID: 1969943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.